PP21 Markers and Consequences of Ovulatory (dys)Function

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Reproductive Endocrinology-Basic
Saturday, April 2, 2016: 11:30 AM-11:45 AM
Room 162 (BCEC)
Chairs:
Kristy M Nicks, PhD, NIAMS, NIH Kelly Government Solutions, Bethesda, MD and Dana Gaddy, PhD, Texas A&M University, College Station, TX

Nothing to Disclose: KMN, DG Disclosure Not Provided: DHA
Rachel Franklin, BA1, Thilo Deckersbach, PhD2, Taylor Huhta, BS3, Amanda R Arulpragasam, BS1, Kathryn L Williams, BA3, Alexandra M Rodman, BA1, Darin D Dougherty, MD2 and Janet E. Hall, M.D., M.Sc.4, (1)Neuropsychiatry Neuroimaging Group, Dept of Psychiatry, Massachusetts General Hospital, Boston, MA
(2)Neuropsychiatry Neuroimaging Group, Dept of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA
(3)Reproductive Endocrine Unit, Dept of Medicine, Massachusetts General Hospital, Boston, MA
(4)Reproductive Endocrine Unit, Dept of Medicine, Massachusetts General Hospital & Harvard Medical School and Intramural Program, Natonal Institute of Environmental Health Sciences, Boston, MA
Poster Board Number: SAT 165
Natalie D Shaw, MD, Clinical Research Branch, National Institute of Environmental Health Sciences, Durham, NC, Tairmae Kangarloo, BS, Reproductive Endocrine Unit, Massachusetts General Hospital, Boston, MA, Patrick M. Sluss, Ph.D., Endocrine Unit, Massachusetts General Hospital, Boston, MA, Judith M. Adams, R.N., Reprod Endo Unit, MA Gen Hosp, Boston, MA, Donald Walt Chandler, PhD, Endocrine Sciences, Laboratory Corporation of America Holdings, Calabasas Hills, CA, David T. Zava, ZRT Laboratory, Beaverton, OR and Janet E. Hall, M.D., M.Sc., Division of Intramural Research, National Institute of Environmental Sciences/NIH, Research Triangle Park, NC
Poster Board Number: SAT 163
Sybil Crawford, PhD1, Joel S Finkelstein, MD2, Ellen Gold, PhD3, Gail A Greendale, MD4, Sioban Harlow5, Hadine Joffe, MD, MSc6, Bhanu Kalra, PhD7, Ajay Kumar, PhD7, Deborah Martin, BS8, Steffenie Merillat, BS9, Anthony Morrison, BSC, MD10, Patrick M. Sluss, Ph.D.11, Rebecca C. Thurston, PhD12 and Nancy Avis, PhD13, (1)Division of Preventive and Behavioral Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA
(2)Mass General Hospital
(3)Public Health Sciences, University of California Davis, Davis, CA
(4)Department of Medicine, University of California, Los Angeles, CA
(5)University of Michigan, Ann Arbor, MI
(6)Psychiatry, Brigham and Women's Hospital, Dana Farber Cancer Institute, & Harvard Medical School, Boston, MA
(7)Ansh Labs, Webster, TX
(8)Epidemiology Data Center, University of Pittsburgh, Pittsburgh, PA
(9)School of Public Health, University of Michigan, Ann Arbor, MI
(10)Sales and Marketing, Ansh Labs, Tampa, FL
(11)Clinical Pathology Core Laboratory, Massachusetts General Hospital, Boston, MA
(12)University of Pittsburgh School of Medicine and Graduate School of Public Health
(13)Wake Forest School of Medicine
Poster Board Number: SAT 164
Brent S. Abel, B.S.1, Alicia Kinton, M.S.N.2, Judith M. Adams, R.N.2, Patrick M. Sluss, Ph.D.2, Sharon Lie Fong, M.D.3, Joop S.E. Laven, M.D., Ph.D.3, Elizabeth C. Wright, Ph.D., M.P.H.1, Kathryn A. Martin, M.D.2, Corrine K. Welt, M.D.4 and Janet E. Hall, M.D., M.Sc.5, (1)NIDDK, NIH
(2)REU, MGH
(3)Erasmus MC
(4)University of Utah
(5)NIEHS, NIH
Poster Board Number: SAT 161

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire